Form D · Biotechnology

Restora Medical, Inc.

Irvine, CA · CIK 0002008412

Offering snapshot reported Jun 18, 2026 · SEC filing

Reported sold: $3.5M
Investors reported: 4
Minimum accepted: $0
First sale: Jan 8, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 18, 2026	Amendment	$3,500,000	$0vs Jan 23, 2024	4	SEC filing
Jun 18, 2026	Amendment	$11,500,000	$0vs May 29, 2026	5	SEC filing
Jun 18, 2026	Amendment	$6,024,999	$0vs Mar 6, 2025	11	SEC filing
May 29, 2026	Initial	$11,500,000	No comparison	5	SEC filing
Mar 6, 2025	Initial	$6,024,999	No comparison	11	SEC filing
Jan 23, 2024	Initial	$3,500,000	No comparison	4	SEC filing

Offering details

Securities: Equity, Debt
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-503184

Source: Form D, filed Jun 18, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Chau Khuong	Director
Quan Ni	Director, Executive, Promoter
Lixiao Wang	Director
Ye Zhang	Director
Tianji Zhu	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

2603 Main St. Suite 770
Irvine, CA, 92614